Latent mitotic vulnerability of AML cells induced by therapeutic agents
R. Niikura, T. Yabushita, S. Yamamoto, H. Suzuki, M. Fukuyama, S. Hata, S. Goyama, T. Kitamura, T. Chinen, D. Kitagawa
This study identifies mitotic vulnerabilities in AML cells induced by therapeutic agents, showing increased cytotoxicity during mitosis compared to S/G2 phase arrest.
bioRxiv · Jun 27, 2024 · PreprintCancer Biology